Remedy Entertainment confirms new Control sales figures and release schedule for Control Resonant

Remedy Entertainment has recently presented its business report for the first quarter of 2026. The report highlights the performance of Control, which has now sold more than 6 million copies, and confirms that Control Resonant remains on track for a 2026 launch. These are important developments for the studio, especially after the disappointing performance of its co-op shooter FBC: Firebreak.

Overview of Control and sales figures

It is notable that Control continues to perform well, even during a period full of challenges for Remedy. Sales figures have risen notably, with increased revenue from game sales and royalties thanks to titles such as Alan Wake 2 and the original Control. Remedy also recently released an iPhone and iPad port of Control, which has contributed to the growing sales.

During the Q1 2026 report, Remedy said Control had maintained solid sales momentum and outperformed the comparison period. This success is supported by promotions and additional visibility tied to the upcoming release of Control Resonant.

Challenges with FBC: Firebreak

Unfortunately, 2025 was a difficult year for Remedy. The co-op shooter FBC: Firebreak was considered a failure, which led to the departure of CEO Tero Virtala. Development on FBC: Firebreak was halted in March 2026. That disappointment marks a major shift in the studio's direction.

Jean-Charles Gaudechon, the new CEO who took over in February 2026, has said the company is focused on preserving what makes Remedy special while pushing to finish Control Resonant. His comments underline the need for focus as the team works toward the launch of the new title.

Remedy's financial situation

Remedy's report shows that total revenue declined slightly, down 1.9% to EUR 13.1 million. Even so, operating profit (EBIT) came in at EUR 1.0 million, representing an operating margin of 7.8%. This suggests the studio has managed to keep costs under control despite falling revenue.

In short, Remedy shows that despite recent setbacks, there is still potential for future growth thanks to the strong performance of existing titles and upcoming releases. The appointment of Jean-Charles Gaudechon may give the studio's strategy and focus a new direction.